Amylin (14-20) (human)

The formation of amyloid deposits by IAPP could play a central role in the pathogenesis of type II diabetes. Besides the amyloidogenic 20-29 region, the domain NFLVHSS (IAPP 14-20) tends to aggregate and seems to be involved in plaque formation. The peptide NFLVHSS (IAPP 14-20) tends to aggregate and seems to be involved in plaque formation.

Online Inquiry

Specification Technical Data Related Products Featured Products Customer reviews and Q&A Useful Tools Publications

CAT#	A12019
CAS	121341-77-3
Synonyms/Alias	L-asparagyl-L-phenylalanyl-L-leucyl-L-valyl-L-histidyl-L-seryl-L-serine
Chemical Name	(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoic acid
M.F/Formula	C36H54N10O11
M.W/Mr.	802.89
Sequence	One Letter Code: NFLVHSS Three-Letter Code: H-Asn-Phe-Leu-Val-His-Ser-Ser-OH

CAT#	Product Name	Inquiry
A12014	Amylin, human, free acid	Inquiry
A12018	5-FAM-Amylin (mouse, rat)	Inquiry
A12002	Amylin (20-29), human	Inquiry
A12006	Amylin (1-13), human	Inquiry
CAD-108	Biotinyl-Amylin (human)	Inquiry

CAT#	Product Name	M.W	Molecular Formula	Inquiry
10-101-20	Goserelin Acetate	1269.43	C59H84N18O14	Inquiry
10-101-59	Liraglutide	3751.2	C172H265N43O51	Inquiry
R1574	Octreotide	1019.24	C₄₉H₆₆N₁₀O₁₀S₂	Inquiry
10-101-139	Myrcludex B			Inquiry
10-101-285	Teduglutide	3752.08	C164H252N44O55S	Inquiry
R1847	Sermaglutide	4114	C187H291N45O59	Inquiry
R1961	Carbetocin	988.2	C45H69N11O12S	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Source#	Synthetic
Storage	Store at -20°C
Solubility	Soluble in DMSO
InChI	InChI=1S/C36H54N10O11/c1-18(2)10-23(42-31(51)24(11-20-8-6-5-7-9-20)41-30(50)22(37)13-28(38)49)33(53)46-29(19(3)4)35(55)43-25(12-21-14-39-17-40-21)32(52)44-26(15-47)34(54)45-27(16-48)36(56)57/h5-9,14,17-19,22-27,29,47-48H,10-13,15-16,37H2,1-4H3,(H2,38,49)(H,39,40)(H,41,50)(H,42,51)(H,43,55)(H,44,52)(H,45,54)(H,46,53)(H,56,57)/t22-,23-,24-,25-,26-,27-,29-/m0/s1
InChI Key	NYWRQILLKJSDDP-UIRCOLITSA-N
Canonical SMILES	CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(CC1=CN=CN1)C(=O)NC(CO)C(=O)NC(CO)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(=O)N)N
Isomeric SMILES	CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(=O)N)N